1. "Breast Medicine Service"
  2. "2012"
Formats
  1. Journal Article (97)
  2. Meeting Abstract (67)
  3. Book Section (2)
Groups
  1. Breast Medicine Service (166)
  2. Department of Medicine (166)
  3. Solid Tumor Oncology Division (166)
  4. Survivorship Research (111)
  5. GSK Faculty (57)
  6. Epidemiology and Biostatistics (44)

More Groups

People
  1. Clifford Hudis (64)
  2. Sujata Patil (27)
  3. Larry Norton (26)
  4. Neal Rosen (21)
  5. Mark Robson (17)
  6. Tiffany Traina (15)

More People

Years
  1. 2012 (166)
Publications
  1. Journal of Clinical Oncology (32)
  2. Cancer Research (30)
  3. Cancer (10)
  4. Annals of Oncology (6)
  5. Breast Cancer Research and Treatment (6)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. American Association for Cancer Research (44)
  2. American Society of Clinical Oncology (34)
  3. Elsevier Inc. (18)
  4. Wiley Blackwell (15)
  5. Springer (13)
  6. Oxford University Press (8)

More Publishers

Results (166)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Norton-Simon hypothesis
    Book Section

    Morris, P. G.; Gilewski, T. A.; Norton, L.
    In Perry, M. C. (Eds.) Perry's The Chemotherapy Source Book. 5th ed (2012)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; Norton, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Lehman, R.; Rege, J.; Wang, W.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Colorectal cancer survivors' needs and preferences for survivorship information
    Meeting Abstract

    Salz, T.; McCabe, M. S.; Blinder, V. S.; Elkin, E. B.; Kemeny, M.; Saltz, L.; Temple, L. K. F.; Oeffinger, K. C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Tesetaxel: Activity of an oral taxane as first-line treatment in metastatic breast cancer
    Meeting Abstract

    Seidman, A. D.; Schwartzberg, L. S.; O'Shaughnessy, J.; D'Andrea, G.; Rubin, P.; Katz, S.; Danesi, H.; Itri, L.; Hudis, C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predicting the Oncotype DX score: An inexpensive guesstimation
    Meeting Abstract

    Pesce, C.; Stempel, M.; Eaton, A.; Patil, S.; Brogi, E.; Potz, B.; Hudis, C.; El-Tamer, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Does unblinding of treatment assignment impact participant perceptions in clinical trials?
    Meeting Abstract

    Partridge, A. H.; Sepucha, K.; O'Neill, A. M.; Miller, K.; Motley, C.; Swaby, R. F.; Schneider, B. P.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save